Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Introduction: Telomere length plays important roles in maintaining genome stability and regulating cell replication and death. Telomerase has functions not only to extend telomere length but also to repair DNA damage. Studies have shown that telomerase may increase cancer cell resistance to DNA-damaging anticancer agents; tamoxifen may suppress telomerase expression in breast cancer cells. This study aimed to investigate the role of telomere length and telomerase activity in breast cancer prognosis. Methods: qPCR and qRT-PCR were used to analyze telomere length and telomerase expression, respectively, in tumor samples of 348 breast cancer patients. Cox regression analysis was performed to examine telomere length and telomerase expression in association with disease-free survival and cause-specific mortality. Results: Telomere length had no relation to tumor features or disease outcomes. Telomerase expression was detected in 53% of tumors. Larger tumors or aggressive disease were more likely to have telomerase expression. Among patients treated with chemotherapy, high telomerase was found to be associated with increased risk of death (hazard ratio (HR) = 3.15; 95% CI: 1.34 to 7.40) and disease recurrence (HR = 2.04; 95% CI: 0.96 to 4.30) regardless of patient age, disease stage, tumor grade, histological type or hormone receptor status. Patients treated with endocrine therapy had different results regarding telomerase: high telomerase appeared to be associated with better survival outcomes. Telomerase expression made no survival difference in patients who received both chemotherapy and endocrine therapy. Conclusions: Overall, telomerase expression was not associated with disease outcome, but this finding may be masked by adjuvant treatment. Patients with high telomerase expression responded poorly to chemotherapy in terms of disease-free and overall survival, but fared better if treated with endocrine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669 · cited 1×
“Telomerase, a ribonucleoprotein complex composed of telomerase reverse transcriptase (TERT), telomerase RNA (TERC) and dyskerin [9], is a nuclear enzyme that increases the length of telomeres.”
BackgroundDemissie, S., Levy, D., Benjamin, E. J., Cupples, L. A., Gardner, J. P., Herbert, A., Kimura, M., Larson, M. G., Meigs, J. B., Keaney, J. F., et al. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00224.x · Cited by 508
Human cell senescence as a DNA damage response
Zglinicki, T. V., Saretzki, G., Ladhoff, J., Fagagna, F. D. D., & Jackson, S. P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.09.034 · Cited by 419 · cited 1×
“Telomeres are repeated sequences of oligonucleotides (TTAGGG) located at the ends of chromosomes, and have important functions in regulating cell replication and maintaining genome integrity [1-3].”
BackgroundHug, N., & Lingner, J. (2006) · Chromosoma · doi:10.1007/s00412-006-0067-3 · Cited by 291
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
Broberg, K., Björk, J., Paulsson, K., Höglund, M., & Albin, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi063 · Cited by 255 · cited 1×
“Telomere shortening has been found to be associated with increased risk of several human cancers, including bladder, lung, esophagus, pancreas, ovary and thyroid [4-8].”
BackgroundHochreiter, A. E., Xiao, H., Goldblatt, E. M., Gryaznov, S. M., Miller, K. D., Badve, S., Sledge, G. W., & Herbert, B.-S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2760 · Cited by 146 · cited 1×
“Based on the experimental observations of in vitro cell cultures and in vivo animal models, telomerase inhibitors can reduce tumorigenicity and suppress breast cancer growth and metastasis [21-23].”
BackgroundEvolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
Telomerase Maintains Telomere Structure in Normal Human Cells
Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Murakami, S., DeCaprio, J. A., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00550-6 · Cited by 70 · cited 1×
“Telomerase inhibitors can suppress the growth and proliferation of tumor cells [17,44,45].”
Background
Cited by
Glioblastoma: pathology, molecular mechanisms and markers
Aldape, K., Zadeh, G., Mansouri, S., Reifenberger, G., & von Deimling, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1432-1 · Cited by 735
Carlson, L. E., Beattie, T. L., Giese‐Davis, J., Faris, P., Tamagawa, R., Fick, L. J., Degelman, E. S., & Speca, M. (2015) · Cancer · doi:10.1002/cncr.29063 · Cited by 194
“However, the relationships between TL and the clinical or pathological features of tumors are still not clearly understood.(13) Recent emerging research has suggested that TL and its enzyme telomerase may be susceptible to psychosocial influences, particularly stress.”
BackgroundTelomere fusion threshold identifies a poor prognostic subset of breast cancer patients
Simpson, K., Jones, R. E., Grimstead, J. W., Hills, R., Pepper, C., & Baird, D. M. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.003 · Cited by 46
The dynamics of telomere length in primary and metastatic colorectal cancer lesions
Kroupa, M., Kubecek, O., Tomasova, K., Hanak, P., Krupova, M., Cervena, K., Siskova, A., Rosendorf, J., Hosek, P., Vodickova, L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35835-9 · Cited by 10
Metadata
- Authors
- Lu, L., Zhang, C., Zhu, G., Irwin, M., Risch, H., Menato, G., Mitidieri, M., Katsaros, D., & Yu, H.
- Venue
- Breast Cancer Research
- Published
- 2011-06-06
- Volume
- 13
- Issue
- 3
- Pages
- R56-R56
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2111720984
- Cited by
- 80
- References
- 9
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. https://app.cochat.ai/papers/10.1186/bcr2893
- The paper
- Lu, L., Zhang, C., Zhu, G., Irwin, M., Risch, H., Menato, G., Mitidieri, M., Katsaros, D., & Yu, H. (2011). Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Research. https://doi.org/10.1186/bcr2893
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.